Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kalaris Therapeutics Inc

    NASDAQ: KLRS · Real-Time Price · USD
    2.50
    0.00 (0.00%)
    At close: Aug 19, 2025, 11:49 AM

    Kalaris Therapeutics Inc Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2025 Q1 2024 Q4 2023
    Period Ending Mar 31, 2025 Mar 31, 2024 Dec 31, 2023
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a
    Operating Income
    		 -16.38M -6.03M -3.46M
    Interest Income
    		 n/a n/a n/a
    Pretax Income
    		 -17.07M -6.88M -3.47M
    Net Income
    		 -17.07M -6.88M -3.47M
    Selling & General & Admin
    		 5.42M 1.1M 498K
    Research & Development
    		 10.96M 4.93M 2.97M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 16.38M 6.03M 3.46M
    Interest Expense
    		 1.56M 117K 39K
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 16.38M 6.03M 3.46M
    Income Tax Expense
    		 n/a n/a n/a
    Shares Outstanding (Basic)
    		 4.05M 18.7M n/a
    Shares Outstanding (Diluted)
    		 4.05M 18.7M n/a
    EPS (Basic)
    		 -2.7 -0.18 n/a
    EPS (Diluted)
    		 -2.7 -0.18 n/a
    EBITDA
    		 -15.51M -6.76M -3.43M
    EBIT
    		 -15.51M -6.76M -3.43M
    Depreciation & Amortization
    		 n/a n/a n/a

    Add to Watchlist